Volume 56, Issue 2, Pages (August 1999)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Virological tools to diagnose and monitor hepatitis C virus infection

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson

Continuous renal replacement therapy in the critically ill patient

Volume 154, Issue 4, Pages (March 2018)

Section 5: Dialysis Interventions for Treatment of AKI

Volume 73, Pages S53-S68 (April 2008)

Volume 155, Issue 5, Pages e2 (November 2018)

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 84, Issue 2, Pages (August 2013)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 68, Issue 5, Pages (November 2005)

Volume 70, Issue 11, Pages (December 2006)

Volume 70, Issue 12, Pages (December 2006)

Acute myocardial infarction in patients with end-stage renal disease

Volume 70, Issue 12, Pages (December 2006)

David Del Bello, Michael J. Ross, Shirish S. Huprikar

Locking of tunneled hemodialysis catheters with gentamicin and heparin

Volume 76, Issue 6, Pages (September 2009)

Effects of hemodialysis on cardiac function

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 61, Issue 2, Pages (February 2002)

Elevated risk of stroke among patients with end-stage renal disease

Nephrology in Latin America, with special emphasis on Brazil

Hepatitis C treatment in patients with kidney disease

Counteracting progression of renal disease: A look into the future

Starting dialysis is dangerous: how do we balance the risk?

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Shannon D. Smith, Marcia A. Wheeler, Marc I. Lorber, Robert M. Weiss

Volume 71, Issue 12, Pages (June 2007)

Volume 87, Issue 5, Pages (May 2015)

Volume 54, Issue 2, Pages (August 1998)

Long-term survival in renal transplant recipients with graft function

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Does equal care give equal outcomes?

The Iranian model of living renal transplantation

Volume 66, Issue 6, Pages (December 2004)

Volume 65, Issue 2, Pages (February 2004)

Volume 72, Issue 8, Pages (October 2007)

Volume 80, Issue 10, Pages (November 2011)

Charles A. Herzog Kidney International

Volume 56, Issue 2, Pages (August 1999)

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Volume 53, Issue 5, Pages (May 1998)

Volume 86, Issue 2, Pages (August 2014)

Volume 70, Issue 5, Pages (September 2006)

The international realities of live donor kidney transplantation

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Familial phenotype differences in PKD11

Volume 57, Issue 2, Pages (October 2000)

Prediction in idiopathic membranous nephropathy

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Volume 60, Issue 2, Pages (August 2001)

Volume 57, Pages S44-S48 (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Ronen Levi, Justin Silver Kidney International

Presentation transcript:

Volume 56, Issue 2, Pages 700-706 (August 1999) Hepatitis C virus genotype does not affect patient survival among renal transplant candidates Svetlozar N. Natov, Johnson Y.N. Lau, Robin Ruthazer, Christopher H. Schmid, Andrew S. Levey, Brian J.G. Pereira Kidney International Volume 56, Issue 2, Pages 700-706 (August 1999) DOI: 10.1046/j.1523-1755.1999.00594.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Survival since the initiation of renal replacement therapy among renal transplant candidates infected with hepatitis C virus (HCV) genotypes 1a (heavy solid line), 1b (long dashed line), or all others (dotted line). Kidney International 1999 56, 700-706DOI: (10.1046/j.1523-1755.1999.00594.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Survival since the initiation of renal replacement therapy among renal transplant candidates infected with a single (solid line) or mixed (dotted line) hepatitis C virus (HCV) infection. Kidney International 1999 56, 700-706DOI: (10.1046/j.1523-1755.1999.00594.x) Copyright © 1999 International Society of Nephrology Terms and Conditions